Past Podcast Episodes

Last week, a research team at the Harvard T.H. Chan School of Public Health presented compelling evidence that the Epstein-Barr Virus (EBV) triggers multiple sclerosis. So, we're taking a deep dive into the role of EBV and MS.

We'll review the breakthrough results of this research and we'll re-share our conversation with one of the researchers in this game-changing study.

We'll review the status of an experimental cell therapy that's designed to remove the EBV virus from infected b-cells in people with progressive MS.

And we'll update you on a clinical trial that's underway to test an EBV vaccine.

We have a lot to talk about! Are you ready for RealTalk MS??!

Researchers at Harvard present compelling evidence that Epstein-Barr Virus (EBV) triggers MS  :22

Dr. Kassandra Munger discusses EBV and MS   4:41

What else do we still need to know?  13:28

ATA-188, EBV, and MS  14:06

Dr. AJ Joshi discusses what scientists are learning from the ATA-188 clinical trial  14:49

What about an EBV vaccine?   27:21

What??? Magic???  28:33

Share this episode  30:23

Be sure to catch MS Got Talent  30:43

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email:  https://realtalkms.com/229

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society COVID-19 Vaccine Guidance for People Living with MS
https://www.nationalmssociety.org/coronavirus-covid-19-information/multiple-sclerosis-and-coronavirus/covid-19-vaccine-guidance

National MS Society Third COVID-19 Vaccine Dose Guidance for People Living with MS
https://www.nationalmssociety.org/About-the-Society/News/Additional-COVID-19-Vaccine-Dose-(Booster)-and-MS

STUDY: Longitudinal Analysis Reveals High Prevalence of Epstein-Barr Virus Associated with Multiple Sclerosis
https://science.org/doi/10.1126/science.abj8222

MS Got Talent LIVE on Jan. 29th at 7PM Eastern/4PM Pacific
https://mssociety.donordrive.com/participant/msgottalent
or https://twitch.tv/mssociety

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 229
Guests: Dr. Kassandra Munger, 

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, EBV, EpsteinBarr, RealTalkMS

 

This special episode of RealTalk MS is sponsored by EMD Serono and MS in the 21st Century.

Cognitive impairment affects more than 50% of the people living with MS. In this special episode of RealTalk MS, we're talking with Dr. Sarah Morrow and Paola Kruger about how people living with MS can work together with their healthcare providers to develop a constructive dialogue about cognition and MS.

Dr. Sarah Morrow is an Associate Professor of Neurology in the Department of Clinical Neurological Sciences at Western University. Dr. Morrow is also the founder of the first MS Cognitive Clinic in London Ontario, and the director of the London Ontario MS Clinic in Canada.

Paola Kruger is a patient advocate who was diagnosed with MS in 2010. Since her diagnosis, Paola has worked with the Multiple Sclerosis Centre in Rome, focusing on projects related to patient engagement while also developing new clinician/patient approaches to managing MS.

Both Dr. Morrow and Paola are active members of the MS in the 21st Century initiative. To learn more about MS in the 21st Century, please visit www.msinthe21stcentury.com.

You're invited to take the MS in the 21st Century survey on the impact of cognitive symptoms on daily life and employment here (link is only active in the U.S.).